Xylo Technologies Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XYLO research report →
Companywww.medigus.com
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease.
- CEO
- Liron Carmel
- IPO
- 2015
- Employees
- 38
- HQ
- Tel Aviv, IL
Price Chart
Valuation
- Market Cap
- $3.77M
- P/E
- -0.61
- P/S
- 0.13
- P/B
- 0.20
- EV/EBITDA
- -0.25
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 22.38%
- Op Margin
- -26.85%
- Net Margin
- -20.19%
- ROE
- -29.00%
- ROIC
- -30.79%
Growth & Income
- Revenue
- $29.86M · -67.45%
- Net Income
- $-6,027,000 · 62.39%
- EPS
- $-8.36 · 11.99%
- Op Income
- $-8,017,000
- FCF YoY
- 77.03%
Performance & Tape
- 52W High
- $5.85
- 52W Low
- $2.71
- 50D MA
- $5.05
- 200D MA
- $4.60
- Beta
- 0.17
- Avg Volume
- 5.18K
Get TickerSpark's AI analysis on XYLO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our XYLO Coverage
We haven't published any research on XYLO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate XYLO Report →